FAdV-4-induced ferroptosis affects fat metabolism in LMH cells

Wenjing Dong1, Ke Du1, Yonghe Ding1

  • 1The Affiliated Hospital of Qingdao University and The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, Qingdao, Shandong Province, China.

PubMed

Insights

Fowl adenovirus serotype 4 (FAdV-4) promotes ferroptosis, a cell death pathway, in liver cells. Inhibiting this process may offer new treatments for hydropericardium syndrome (HPS) and fatty liver disease.

Area of Science:

  • Cell Biology
  • Virology
  • Pathology

Background:

  • Ferroptosis is iron-dependent cell death involving lipid radical accumulation.
  • Viral infections and liver diseases like fatty liver are linked to ferroptosis.
  • Fowl adenovirus serotype 4 (FAdV-4) causes hydropericardium syndrome (HPS) and affects fat metabolism.

Purpose of the Study:

  • To investigate the role of ferroptosis in FAdV-4 infection.
  • To explore the molecular mechanisms of FAdV-4-induced ferroptosis.
  • To assess the therapeutic potential of inhibiting ferroptosis in FAdV-4 infection.

Main Methods:

  • FAdV-4 infection in cell models.
  • Analysis of the p53-SLC7A11-GPX4 pathway.
  • Assessment of lipid peroxidation.
  • Administration of ferrostatin-1 (an inhibitor of ferroptosis).
  • Evaluation of FAdV-4-induced fatty liver.

Main Results:

  • FAdV-4 infection activates ferroptosis through the p53-SLC7A11-GPX4 axis.
  • Ferrostatin-1 significantly reduces FAdV-4-mediated lipid peroxidation and cell death.
  • FAdV-4-induced fatty liver is associated with increased ferroptotic activity.

Conclusions:

  • FAdV-4 promotes ferroptosis via a specific molecular pathway.
  • Inhibition of ferroptosis can mitigate FAdV-4-induced cell damage and fatty liver.
  • Targeting ferroptosis presents a potential therapeutic strategy for HPS.